Equities researchers at StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHX – Get Free Report) in a note issued to investors on Wednesday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock.
Athersys Price Performance
The company has a market capitalization of $833,000.00, a price-to-earnings ratio of -0.01 and a beta of -0.90. Athersys has a 12-month low of $0.01 and a 12-month high of $1.99.
About Athersys
Want More Great Investing Ideas?
Further Reading
- Five stocks we like better than Athersys
- Insider Buying Explained: What Investors Need to Know
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- With Risk Tolerance, One Size Does Not Fit All
- Breakout Alert: Qualcomm Just Hit The Rally Button
- Investing in Travel Stocks Benefits
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.